Pharma Digitalization Roadmap

Pharma digitalization roadmap services for pharmaceutical manufacturers. The engagement covers the current state assessment, the target state design, the sequencing, the business case, the governance, and the execution support.

Current state assessment

The current state assessment covers the systems inventory, the operational maturity, the data maturity, the GxP maturity, the IT/OT maturity, and the cybersecurity maturity.

Target state design

The target state design covers the future architecture, the future operating model, the future data model, the future GxP model, the future IT/OT model, and the future cybersecurity model.

Sequencing and business case

The sequencing covers the phases, the dependencies, the risks, the resources, the timeline, and the budget. The business case covers the value, the cost, the risk, the ROI, the payback period, and the strategic value.

How to use this page

Use this Pharma Digitalization Roadmap page as a planning checkpoint before vendor selection, architecture review, validation scoping or implementation sequencing. The strongest next step is to compare the guidance with your current SOPs, system inventory, batch records, data flows and QA review routines so the discussion starts from evidence instead of assumptions.

Evidence to prepare

For Pharma Digitalization Roadmap, prepare the records, owners, risks and decision criteria linked to current state assessment, target state design, sequencing and business case. Useful evidence includes current process maps, interface lists, audit trail expectations, exception workflows, data retention rules and the business reason for changing the current operating model.

Frequently asked questions

How long does a digitalization roadmap take?

A typical digitalization roadmap takes 8-12 weeks.

What is the typical digitalization timeline?

A typical pharmaceutical digitalization timeline is 3-5 years for the full scope.